Skip to Content

PLIVA 482 (Theophylline extended-release 200 mg)

Pill with imprint PLIVA 482 is White, Elliptical / Oval and has been identified as Theophylline extended-release 200 mg. It is supplied by Pliva Inc..

Theophylline is used in the treatment of apnea of prematurity; asthma, maintenance; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PLIVA 482

Theophylline extended-release 200 mg PLIVA 482
Theophylline extended-release 200 mg PLIVA 482 Front
Theophylline extended-release 200 mg PLIVA 482 Back
Theophylline extended-release 200 mg PLIVA 482 Front
Theophylline extended-release 200 mg PLIVA 482 Back
Theophylline extended-release 200 mg PLIVA 482

Theophylline extended-release

Imprint
PLIVA 482
Strength
200 mg
Color
White
Size
12.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Methylxanthines
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pliva Inc.
National Drug Code (NDC)
50111-0482
Inactive Ingredients
hypromellose 2208 (100 mPa.s), hypromellose 2208 (100000 mPa.s), lactose anhydrous, magnesium stearate, povidone k30

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.